Cefepime-Induced Neurotoxicity: A Systematic Review

NCSE is common in patients who have been given Cefepime; EEG should be considered for those experiencing Altered Mental Status

CAFEPIME: NCSE is common in patients who have been given Cefepime; EEG should be considered for those experiencing Altered Mental Status Cefepime-induced neurotoxicity is challenging to recognize in the critically ill due to widely varying symptoms that are common in ICU patients. This adverse reaction can occur despite appropriate dosing, usually resolves with drug interruption, […]

Non-Convulsive Seizures in the Encephalopathic Critically Ill Cancer Patient Does Not Necessarily Portend a Poor Prognosis

Non-convulsive seizures in the encephalopathic critically ill cancer patient does not necessarily portend a poor prognosis

CANCER: NCSE in critically ill cancer patients should be promptly diagnosed and treated NCS in critically ill cancer patients is associated with abnormalities on brain imaging and lower prevalence of organ failure. Diagnosis and treatment of NCS should be a priority in encephalopathic cancer patients, as they can have lower mortality than non-seizing patients. Opposite […]

360 N Pastoria Avenue
Sunnyvale, CA 94085, USA

Contact Us: EEG@ceribell.com

Technical Support: 1.800.763.0183

General Inquiries: 1.800.436.0826

Caution: Federal (US) law restricts Ceribell devices to sale by or on the order of a physician. Ceribell devices are intended to be used by trained healthcare providers in a professional healthcare facility environment. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

© 2023 Ceribell, Inc. All Rights Reserved           MK-00002, rev AK